• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials.

作者信息

Di Minno Matteo Nicola Dario, Ageno Walter, Lupoli Roberta, Conte Giulia, van Es Nick, Buller Harry R, Dentali Francesco

机构信息

Dept of Advanced Biomedical Sciences, Division of Cardiology, Federico II University, Naples, Italy

Dept of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.

出版信息

Eur Respir J. 2017 Sep 27;50(3). doi: 10.1183/13993003.01097-2017. Print 2017 Sep.

DOI:10.1183/13993003.01097-2017
PMID:28954772
Abstract
摘要

相似文献

1
Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials.直接口服抗凝剂用于治疗癌症患者急性静脉血栓栓塞症：一项随机对照试验的荟萃分析
Eur Respir J. 2017 Sep 27;50(3). doi: 10.1183/13993003.01097-2017. Print 2017 Sep.
2
Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study.直接口服抗凝剂与维生素K拮抗剂及低分子量肝素相比用于预防癌症患者静脉血栓栓塞的荟萃分析研究
Int J Cardiol. 2017 Mar 1;230:214-221. doi: 10.1016/j.ijcard.2016.12.168. Epub 2016 Dec 27.
3
[What role for the direct oral anticoagulants in oncology?].直接口服抗凝剂在肿瘤学中起什么作用？
Bull Cancer. 2018 Jul-Aug;105(7-8):631-633. doi: 10.1016/j.bulcan.2018.05.015. Epub 2018 Jun 28.
4
Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.癌症患者静脉血栓栓塞症的治疗和二级预防。当前策略和新的治疗选择。
Hamostaseologie. 2012;32(2):139-44. doi: 10.5482/ha-1168. Epub 2011 Aug 8.
5
Efficacy of novel oral anticoagulants in active cancer patients: Using the venous thromboembolism protocol for an umbrella meta-analysis.新型口服抗凝药在活动性癌症患者中的疗效：采用静脉血栓栓塞方案进行伞状荟萃分析。
Asian J Surg. 2024 Jun;47(6):2708-2709. doi: 10.1016/j.asjsur.2024.03.103. Epub 2024 Apr 26.
6
Direct oral anticoagulants for the treatment of unprovoked venous thromboembolism: a meta-analysis of randomised controlled trials.直接口服抗凝剂治疗非诱因性静脉血栓栓塞症：一项随机对照试验的荟萃分析
Blood Transfus. 2015 Jul;13(3):391-5. doi: 10.2450/2014.0184-14. Epub 2014 Nov 25.
7
The incidence of venous thromboembolism in cancer patients: a real-world analysis.癌症患者静脉血栓栓塞的发生率：一项真实世界分析。
Clin Adv Hematol Oncol. 2012 Jan;10(1):40-2.
8
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients.新型口服抗凝剂（NOACs）在癌症患者中的作用。
Adv Exp Med Biol. 2017;906:137-148. doi: 10.1007/5584_2016_112.
9
Biomarkers of venous thromboembolism in cancer: a silent echo from local events?癌症患者静脉血栓栓塞的生物标志物：局部事件的无声回响？
Biomark Med. 2019 May;13(7):507-509. doi: 10.2217/bmm-2019-0132. Epub 2019 May 29.
10
New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.新型抗凝药物在癌症相关静脉血栓栓塞症患者中的治疗应用。
Best Pract Res Clin Haematol. 2013 Jun;26(2):163-9. doi: 10.1016/j.beha.2013.07.004. Epub 2013 Jul 20.

引用本文的文献

1
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis.直接口服抗凝剂与低分子量肝素治疗癌症相关血栓形成的成本效益分析
Thromb J. 2021 Sep 29;19(1):68. doi: 10.1186/s12959-021-00319-1.
2
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.美国血液学会 2021 年静脉血栓栓塞症管理指南：癌症患者的预防和治疗。
Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442.
3
Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis.
直接口服抗凝剂对癌症合并静脉血栓栓塞症患者的净临床获益：一项系统评价与权衡分析
Front Cardiovasc Med. 2020 Nov 12;7:586020. doi: 10.3389/fcvm.2020.586020. eCollection 2020.
4
Direct versus conventional anticoagulants for treatment of cancer associated thrombosis: a pooled and interaction analysis between observational studies and randomized clinical trials.直接抗凝剂与传统抗凝剂治疗癌症相关血栓形成的比较：观察性研究与随机临床试验的汇总及交互分析
Ann Transl Med. 2020 Feb;8(4):95. doi: 10.21037/atm.2019.12.152.
5
Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism.直接口服抗凝剂预防癌症相关静脉血栓栓塞症风险的疗效和安全性。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619853629. doi: 10.1177/1076029619853629.
6
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis.直接口服抗凝剂与低分子量肝素在癌症患者中的疗效和安全性：系统评价和荟萃分析。
J Thromb Thrombolysis. 2019 Oct;48(3):400-412. doi: 10.1007/s11239-019-01871-4.
7
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer: A Systematic Review and Trade-Off Analysis From 9 Randomized Controlled Trials.非维生素K拮抗剂口服抗凝剂用于癌症患者静脉血栓栓塞预防的净临床获益：一项基于9项随机对照试验的系统评价与权衡分析
Front Pharmacol. 2018 Jun 12;9:575. doi: 10.3389/fphar.2018.00575. eCollection 2018.